Year archive

ROQUEFORT THERAPEUTICS PLC — 2026 filings

All 15 regulatory filings released by ROQUEFORT THERAPEUTICS PLC (ROQ) in 2026, sourced directly from the official regulator.

15 Filings

2026 Period

2026 filings (15)

Filing	Released	Lang
Issue of Equity Share Issue/Capital Change	2026-05-29	English
Notice of Annual General Meeting Report Publication Announcement	2026-05-27	English
Commencement of Trading on US OTCQB Venture Market Regulatory Filings	2026-05-19	English
Attendance at Endless Frontier Labs 2026 Regulatory Filings	2026-05-07	English
Appointment of Non-Executive Director Board/Management Information	2026-05-07	English
Annual Report & Financial Statements Annual Report FY 2025	2026-05-06	English
Clinical Trial Update Regulatory Filings	2026-04-08	English
Total Voting Rights Declaration of Voting Results & Voting Rights Announcements	2026-04-01	English
Admission to Trading and First Day of Dealings Share Issue/Capital Change	2026-03-27	English
Investor Presentation Investor Presentation	2026-03-26	English
Result of General Meeting Declaration of Voting Results & Voting Rights Announcements	2026-03-26	English
Lyramid SPA & MK Cell License Update M&A Activity	2026-03-25	English
Proposed Acquisition and Fundraise of £8.5 million Regulatory Filings	2026-03-02	English
Transaction Update & Notice of Intention to Delist Delisting Announcement	2026-02-25	English
Research Note Published Report Publication Announcement	2026-01-15	English